Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China flag China · Delayed Price · Currency is CNY
16.00
-1.40 (-8.05%)
Aug 24, 2026, 3:04 PM CST

SHE:300482 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
302.49462.53828.69840.31,163996.15
Short-Term Investments
-374.3562.86623.04200.26-
Trading Asset Securities
1,7961,2641,306722.45938.07572.73
Cash & Short-Term Investments
2,0982,1012,1982,1862,3011,569
Cash Growth
25.89%-4.39%0.55%-5.00%46.66%3.84%
Accounts Receivable
697.13791.881,130599.87540.97501.78
Other Receivables
54.7149.2644.2551.7266.664.7
Receivables
751.84841.141,174651.59607.57566.48
Inventory
323.43280.58359.56351.4399.97386.24
Other Current Assets
601.5178.2254.1744.574263.9
Total Current Assets
3,7753,3013,7863,2333,3502,586
Property, Plant & Equipment
1,3871,4541,4841,3531,189906.09
Long-Term Investments
1,0741,3161,391709.481,284971.42
Goodwill
108.97108.97111.42111.42115.3742.51
Other Intangible Assets
241.15245.69205.51194.52203.71208.11
Long-Term Deferred Tax Assets
90.88112.6976.1857.4753.8642.77
Long-Term Deferred Charges
40.3741.0256.4680.0365.0469.76
Other Long-Term Assets
22.422.3444.5932.8339.4129.66
Total Assets
6,7416,6027,1555,7726,3014,856

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
265.52210.81288.37130.46320.08399.99
Accrued Expenses
87.55105.45201.41193.5229.74184.01
Short-Term Debt
-0.0114.854.26208.4219.14
Current Portion of Long-Term Debt
606.23588.39---12.53
Current Portion of Leases
-3.995.4119.0116.8628.24
Current Income Taxes Payable
5.560.4642.621.8458.734.69
Current Unearned Revenue
106.7375.6677.172.88236.3180.55
Other Current Liabilities
67.1254.11191.7342.2970.9162.4
Total Current Liabilities
1,1391,039821.46484.231,141791.54
Long-Term Debt
--570.97552.84532.49510.69
Long-Term Leases
7.279.2614.3327.6911.1910.42
Long-Term Unearned Revenue
46.344.5447.9437.2123.19.4
Long-Term Deferred Tax Liabilities
29.3735.4449.6655.1255.7529.7
Total Liabilities
1,2321,1281,5041,1571,7641,352

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
468.09468.08481.42444.52444.51444.95
Additional Paid-In Capital
1,4041,3991,458765.52775.53787.01
Retained Earnings
3,5773,5573,8073,4333,1662,101
Treasury Stock
-30.09-30.09-171.02-132.46-157.3-139.25
Comprehensive Income & Other
28.2121.2-21.295.9115.39159.18
Total Common Equity
5,4475,4155,5544,5164,3443,353
Minority Interest
61.5758.9395.998.66193.8150.97
Shareholders' Equity
5,5085,4745,6504,6154,5383,504
Total Liabilities & Equity
6,7416,6027,1555,7726,3014,856

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
613.5601.65605.57603.8768.96581.01
Net Cash (Debt)
1,4851,5001,5921,5821,532987.87
Net Cash Growth
39.62%-5.81%0.65%3.27%55.07%9.88%
Net Cash Per Share
3.113.093.433.573.472.23
Filing Date Shares Outstanding
473.6506.3477.87440.96441.26444.95
Total Common Shares Outstanding
473.6506.3477.87440.96441.26444.95
Working Capital
2,6372,2622,9642,7492,2091,794
Book Value Per Share
11.5010.6911.6210.249.847.54
Tangible Book Value
5,0975,0605,2374,2104,0253,102
Tangible Book Value Per Share
10.769.9910.969.559.126.97
Buildings
-997.331,007530.37447.3436.03
Machinery
-1,1131,0711,021940.43741.37
Construction In Progress
-17.255.12290.84199.1416.38